You just read:

Cryoport Expands Agreement with Stemedica to Support a Phase II Clinical Trial to Assess a Stem Cell Therapy for the Treatment of Alzheimer's Disease

News provided by

Cryoport, Inc.

Aug 11, 2016, 08:00 ET